Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

SAVA | Cassava Sciences Inc

Index	RUT	P/E	-	EPS (ttm)	-2.19	Insider Own	6.19%	Shs Outstand	41.74M	Perf Week	-8.33%
Market Cap	711.39M	Forward P/E	-	EPS next Y	-1.04	Insider Trans	1.90%	Shs Float	39.37M	Perf Month	-13.12%
Income	-90.04M	PEG	-	EPS next Q	-0.78	Inst Own	28.29%	Short Float / Ratio	34.81% / 14.69	Perf Quarter	-28.69%
Sales	0.00M	P/S	-	EPS this Y	-52.11%	Inst Trans	5.25%	Short Interest	13.70M	Perf Half Y	-27.75%
Book/sh	4.28	P/B	3.96	EPS next Y	63.84%	ROA	-42.41%	Target Price	112.00	Perf Year	-62.49%
Cash/sh	4.01	P/C	4.22	EPS next 5Y	-	ROE	-45.28%	52W Range	16.55 - 50.77	Perf YTD	-42.62%
Dividend	-	P/FCF	-	EPS past 5Y	-0.83%	ROI	-50.20%	52W High	-66.61%	Beta	0.03
Dividend %	-	Quick Ratio	9.75	Sales past 5Y	0.00%	Gross Margin	-	52W Low	2.42%	ATR	1.00
Employees	26	Current Ratio	9.75	Sales Q/Q	-	Oper. Margin	0.00%	RSI (14)	33.24	Volatility	4.21% 5.65%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-30.66%	Profit Margin	-	Rel Volume	0.58	Prev Close	17.07
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Aug 03 BMO	Payout	-	Avg Volume	933.18K	Price	16.95
Recom	1.00	SMA20	-13.69%	SMA50	-13.00%	SMA200	-32.03%	Volume	541,057	Change	-0.70%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-16-22	Downgrade	B. Riley Securities	Buy → Neutral	$44
Jul-15-21	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$100
Jul-07-21	Reiterated	Maxim Group	Buy	$80 → $190
Apr-27-21	Initiated	B. Riley Securities	Buy	$78
Feb-16-21	Reiterated	H.C. Wainwright	Buy	$20 → $66
Oct-23-20	Initiated	Cantor Fitzgerald	Overweight	$24
Sep-23-20	Upgrade	H.C. Wainwright	Neutral → Buy	$20
May-18-20	Downgrade	H.C. Wainwright	Buy → Neutral
May-15-20	Downgrade	Maxim Group	Buy → Hold
Jan-10-20	Reiterated	Maxim Group	Buy	$3 → $12

Sep-18-23 09:15AM	Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimers Disease (GlobeNewswire) -5.31%
Sep-14-23 06:30AM	The 7 Best Meme Stocks to Buy Now: September 2023 (InvestorPlace)
Sep-13-23 05:20PM	Cassava Sciences Announces Science Publication That Confirms Mechanism of Action of Simufilam, a Novel Drug Candidate for People with Alzheimers Disease (GlobeNewswire)
Sep-11-23 09:10AM	Cassava Sciences Announces Science Publication That Confirms Mechanism of Action of Simufilam, a Novel Drug Candidate for People with Alzheimers Disease (GlobeNewswire)
Sep-06-23 09:15AM	Cassava Sciences Invited to Present in Four Upcoming Investor Conferences (GlobeNewswire)
07:30AM	Loading…
Aug-29-23 07:30AM	16 Most Shorted Stocks Right Now (Insider Monkey) +8.87%
Aug-03-23 09:07AM	Cassava Sciences Reports Q2 2023 Financial Results and Operating Updates (GlobeNewswire)
Jul-29-23 11:30AM	Top 12 Small-Cap Stocks With Highest Upside Potential (Insider Monkey)
Jul-13-23 07:31AM	Why These 3 Stocks Are the Worst Ways to Play Biotech Right Now (InvestorPlace)
Jul-05-23 11:44AM	Why Shares of Cassava Sciences Are Dropping Wednesday (Motley Fool) -12.95%
09:15AM	Oral Simufilam Slowed Cognitive Decline in a Randomized Withdrawal Trial of Mild-to-Moderate Alzheimers Disease (GlobeNewswire)
Jun-27-23 09:15AM	New Research Shows Simufilam Suppresses Overactive mTOR (GlobeNewswire)
Jun-12-23 10:19AM	Companies Like Cassava Sciences (NASDAQ:SAVA) Are In A Position To Invest In Growth (Simply Wall St.)
09:15AM	New Publication Highlights Basic Science Supporting Simufilam (GlobeNewswire)
Jun-01-23 09:15AM	Cassava Sciences to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
12:06PM	Loading…
May-30-23 12:06PM	Cassava (SAVA) Up on Progress With Alzheimers Disease Study (Zacks)
May-23-23 09:50AM	3 Biotech Stocks to Avoid Like the Plague (InvestorPlace)
May-12-23 04:39PM	Why Shares of Cassava Sciences Jumped This Week (Motley Fool) -5.06%
May-11-23 02:40PM	Cassava Sciences Stock Clears Benchmark, Hitting 80-Plus RS Rating (Investor's Business Daily)
09:15AM	Cassava Sciences Completes Patient Dosing in a Randomized Controlled Trial of Simufilam in Alzheimers Disease (GlobeNewswire)
May-08-23 09:15AM	New Data by Academic Researchers Highlights Biological Activity of Simufilam on Filamin A (GlobeNewswire)
May-01-23 09:00AM	Cassava Sciences Reports Q1 2023 Financial Results and Operating Updates (GlobeNewswire)
Apr-26-23 09:12AM	Cassava Sciences to Present at the 2023 H.C. Wainwright Investor Conference (GlobeNewswire)
Mar-09-23 09:45AM	3 Short-Squeeze Stocks to Keep on Your Radar (InvestorPlace)
Mar-04-23 07:20AM	The three-year returns have been massive for Cassava Sciences (NASDAQ:SAVA) shareholders despite underlying losses increasing (Simply Wall St.)
Mar-03-23 07:07AM	Q4 2022 Lexicon Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-28-23 09:15AM	Cassava Sciences Reports Full-year 2022 Financial Results and Operating Updates (GlobeNewswire)
Feb-24-23 01:29PM	3 Drug Stocks to Watch as Alzheimers Clinical Trials End (InvestorPlace)
Feb-08-23 09:15AM	Cassava Sciences Announces Patient Enrollment Update for Phase 3 Studies of Simufilam for the Treatment of Alzheimers Disease (GlobeNewswire)
Feb-01-23 08:55AM	3 Big Reasons to Sell Cassava Sciences Stock Right Now (Motley Fool)
08:27PM	Loading…
Jan-25-23 08:27PM	Why the Dip in Cassava Sciences (SAVA) Stock Shouldnt Spook You (TipRanks) -6.62%
Jan-24-23 04:06PM	Cassava Plummets As 'Highly Desirable' Alzheimer's Results Don't Cut It With Investors (Investor's Business Daily) -19.21%
12:22PM	Cassava Sciences Shares Fall On Phase 2 Alzheimer's Trial Results (Benzinga)
09:15AM	Cassava Sciences Announces Positive Top-Line Clinical Results in Phase 2 Study Evaluating Simufilam in Alzheimers Disease (GlobeNewswire)
Jan-18-23 10:35AM	Cassava Sciences Stock Shows Big Jump In Its Relative Strength Rating (Investor's Business Daily)
Jan-12-23 09:40AM	Is Mesa Laboratories (MLAB) Outperforming Other Medical Stocks This Year? (Zacks)
Jan-03-23 09:16AM	Cassava Sciences, Inc. (NASDAQ:SAVA) most popular amongst individual investors who own 69% of the shares, institutions hold 25% (Simply Wall St.) -6.03%
Dec-20-22 09:15AM	Cassava Sciences Mourns the Death of Board Member and Officer Nadav Friedmann, PhD, MD (GlobeNewswire)
Dec-06-22 09:15AM	Cassava Sciences Announces Completion of Dosing in Open-label Study of Simufilam for Alzheimers Disease (GlobeNewswire)
Nov-22-22 12:30PM	Cassava Sciences Announces Closing of $50 Million Registered Direct Offering (GlobeNewswire)
Nov-18-22 01:30PM	Cassava Sciences Announces $50 Million Registered Direct Offering of Common Stock (GlobeNewswire)
Nov-16-22 10:43AM	7 Stocks Rattled by Corporate Scandals and Shenanigans in 2022 (InvestorPlace) -13.04%
Nov-15-22 10:00AM	Lexicon's Experimental Drug Shows Significant, Consistent Benefits In Diabetic Neuropathy Study (Benzinga)
Nov-14-22 03:54PM	Cassava Sciences stock pops after rival experiences setback in Alzheimers research (Yahoo Finance Video) +9.44%
Nov-07-22 09:00AM	Cassava Sciences Reports Third Quarter Financial Results for 2022 and Business Updates (GlobeNewswire)
06:15AM	What the Latest Controversy Really Means for SAVA Stock (InvestorPlace)
Nov-04-22 10:49AM	Short sellers hit back at Cassava lawsuit against them: We stand behind everything we wrote (MarketWatch)
Nov-03-22 09:15AM	Cassava Sciences Files Lawsuit Against Perpetrators of Short and Distort Campaign (GlobeNewswire)
Nov-01-22 02:21PM	Cassava Sciences (SAVA) to Report Q3 Earnings: What's in Store? (Zacks)
Oct-31-22 05:50PM	Cassava Sciences, Inc. (SAVA) Dips More Than Broader Markets: What You Should Know (Zacks)
06:15AM	A New Study Makes Cassava Sciences Stock an Interesting Buy (InvestorPlace)
Oct-27-22 09:15AM	Cassava Sciences Announces Expansion of Leadership Team (GlobeNewswire)
Oct-25-22 05:50PM	Cassava Sciences, Inc. (SAVA) Gains But Lags Market: What You Should Know (Zacks)
Oct-17-22 05:50PM	Cassava Sciences, Inc. (SAVA) Stock Sinks As Market Gains: What You Should Know (Zacks)
Oct-13-22 09:15AM	Cassava Sciences Announces Initiation of an Open-label Extension Study (GlobeNewswire)
Oct-11-22 06:00PM	Cassava Sciences, Inc. (SAVA) Dips More Than Broader Markets: What You Should Know (Zacks)
06:00AM	Dont Let Misconduct Allegations Cloud Your Perception of SAVA Stock (InvestorPlace)
Oct-05-22 06:15AM	2 Signals to Watch Before Buying SAVA Stock (InvestorPlace)
Sep-30-22 10:35AM	How High Can SAVA Stock Go Once the Controversy Clears? (InvestorPlace)
Sep-29-22 06:15PM	Cassava Sciences, Inc. (SAVA) Stock Moves -1.76%: What You Should Know (Zacks)
Sep-27-22 01:11PM	Caution! Its Not Safe to Jump on the SAVA Stock Hype Train. (InvestorPlace)
Sep-23-22 04:11PM	Cassava Plummets After Refuting New Claims Around Data Tampering Investigation (Investor's Business Daily) -18.00%
01:43PM	Pain Therapeutics Stock Shows Rising Price Performance With Jump To 97 RS Rating (Investor's Business Daily)
09:19AM	10 Most Shorted Stocks in September (Insider Monkey)
Sep-16-22 06:15PM	Cassava Sciences, Inc. (SAVA) Dips More Than Broader Markets: What You Should Know (Zacks)
Sep-09-22 12:08PM	16 Best Penny Stocks to Buy Now (Insider Monkey) +10.77%
Sep-08-22 09:15AM	Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference (GlobeNewswire)
Sep-05-22 08:01PM	Strong Insider Buying Makes These 2 Stocks Attractive (TipRanks)
Aug-18-22 01:06PM	Cassava Insiders Got A Lot Richer As Shares Rebound Following Refutation of Data Manipulation Claims (Benzinga)
09:15AM	No Evidence of Data Manipulation in Science Publication on Simufilam (GlobeNewswire)
Aug-17-22 01:40PM	Cassava Sciences, Blue Apron, and Revlon Stocks Exploded Out of the Gate Wednesday Morning (Motley Fool) +27.26%
Aug-16-22 06:09PM	Top after-hours movers: Apple, Cassava Sciences, Canoo, Digital World Acquisition Corp. (Yahoo Finance)
05:10PM	Stocks to watch: Apple, Digital World Acquistion Corp, Cassava Science, Canoo (Yahoo Finance Video)
Aug-03-22 09:15AM	Cassava Sciences Reports Second Quarter Financial Results for 2022, Mid-year Corporate Update and Interim Analysis of Open-label Study (GlobeNewswire)
Jul-29-22 01:29PM	10 Stocks to Sell Before They Die (InvestorPlace)
Jul-27-22 02:58PM	Cassava's stock dives 21% after report citing alleged criminal probe of data from Alzheimer's drug trial (MarketWatch) -13.95%
01:36PM	Cassava Sciences Responds to Media Reports (GlobeNewswire)
10:08AM	We're Not Very Worried About Cassava Sciences' (NASDAQ:SAVA) Cash Burn Rate (Simply Wall St.)
07:10AM	Cassava Sciences Shares Plunge After Criminal Investigation Report (Benzinga)
06:05AM	Exclusive-Cassava Sciences faces U.S. criminal probe tied to Alzheimer's drug, sources say (Reuters)
Jul-26-22 06:15PM	Cassava Sciences, Inc. (SAVA) Gains As Market Dips: What You Should Know (Zacks)
Jul-24-22 10:00AM	7 Meme Stocks Trading at a Massive Discount Right Now (InvestorPlace)
Jun-24-22 06:15PM	Cassava Sciences, Inc. (SAVA) Stock Sinks As Market Gains: What You Should Know (Zacks)
Jun-16-22 06:15PM	Cassava Sciences, Inc. (SAVA) Stock Moves -1.38%: What You Should Know (Zacks)
May-25-22 11:32AM	The 7 Best Meme Stocks to Buy Now (InvestorPlace) +6.30%
May-05-22 09:00AM	Cassava Sciences Reports First Quarter Financial Results for 2022 and Updates on Phase 3 Clinical Program (GlobeNewswire)
May-04-22 08:48AM	Cassava Sciences May Be Heading Below $10 Per Share (InvestorPlace)
Apr-29-22 02:40PM	Stay Far Away From Cassava Sciences Amid Data Integrity Criticisms (InvestorPlace)
Apr-28-22 05:50PM	Cassava Sciences, Inc. (SAVA) Stock Sinks As Market Gains: What You Should Know (Zacks)
Apr-26-22 03:03PM	Take Full Advantage of Weakness in Cassava Sciences Stock (InvestorPlace)
Apr-25-22 03:11PM	Cassava Sciences Is a Worthwhile Bet to Consider (InvestorPlace) +8.42%
09:00AM	Cassava Sciences Invited to Participate in B. Riley Securities Neuroscience Conference (GlobeNewswire)
Apr-19-22 03:17PM	Cassava Sciences (NASDAQ:SAVA) has More Than Enough Funding to Function Until the Approval Process is Finished, but Investors may Need to be Ready for a Long Wait (Simply Wall St.) -11.26%
Apr-15-22 09:30AM	10 Meme Stocks Redditors are Buying in April (Insider Monkey)
Apr-14-22 07:14PM	Top Sports Betting Stocks for Q2 2022 (Investopedia)
Apr-11-22 05:04PM	Cassava Sciences Is Worth Considering After Hitting Its Latest Trough (InvestorPlace)
03:49PM	Is There An Opportunity With Boyd Gaming Corporation's (NYSE:BYD) 41% Undervaluation? (Simply Wall St.)
Apr-08-22 08:59AM	Biogen (BIIB) Down as Medicare Limits Coverage for Aduhelm (Zacks)
Apr-07-22 05:29PM	Cassava Stock: Despite Overhangs, the Risk-Reward Looks Appealing, Says Analyst (TipRanks)
Apr-06-22 06:11PM	Top 10 Stocks Billionaire David Einhorn Just Added to His Portfolio (Insider Monkey) -6.50%

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer's disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ROBERTSON SANFORD	Director	Aug 23	Buy	17.45	30,000	523,500	886,851	Aug 24 04:06 PM
Barry Richard	Director	Aug 22	Buy	16.65	16,571	275,907	293,477	Aug 23 04:58 PM
Barry Richard	Director	Aug 21	Buy	16.80	1,906	32,021	276,906	Aug 23 04:58 PM
SCANNON PATRICK J MD PHD	Director	Jun 12	Option Exercise	0.95	1,000	950	1,000	Jun 12 04:53 PM
BARBIER REMI	President and CEO	May 24	Option Exercise	16.87	71,428	1,204,990	782,002	May 25 05:11 PM
BARBIER REMI	President and CEO	May 24	Option Exercise	16.87	14,285	240,988	390,397	May 25 05:11 PM
ROBERTSON SANFORD	Director	May 10	Option Exercise	17.79	9,284	165,170	856,851	May 10 04:08 PM
GUSSIN ROBERT Z	Director	May 01	Option Exercise	17.79	9,284	165,170	17,694	May 02 04:04 PM
O DONNELL MICHAEL J	Director	Mar 07	Option Exercise	18.13	7,142	129,484	12,012	Mar 08 04:12 PM
Barry Richard	Director	Mar 07	Buy	25.76	77,276	1,990,630	275,000	Mar 08 04:07 PM
Barry Richard	Director	Mar 06	Buy	26.13	11,565	302,193	197,724	Mar 08 04:07 PM
FRIEDMANN NADAV	Chief Medical Officer	Oct 03	Option Exercise	0.95	9,376	8,907	79,910	Oct 03 06:01 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SAVA | Cassava Sciences Inc

Upgrade your FINVIZ experience